{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:08:01Z","timestamp":1790971681104,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014803","name":"European Food Safety Authority","doi-asserted-by":"publisher","award":["OC\/EFSA\/SCER\/2021\/13"],"award-info":[{"award-number":["OC\/EFSA\/SCER\/2021\/13"]}],"id":[{"id":"10.13039\/100014803","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programma Operativo Nazionale","award":["REACT-EU IV.5 2014-2020"],"award-info":[{"award-number":["REACT-EU IV.5 2014-2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00204-026-04377-0","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:43:56Z","timestamp":1776977036000},"page":"3073-3090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanistic insights into PFAS-induced effects on B lymphocyte activation and antibody secretion"],"prefix":"10.1007","volume":"100","author":[{"given":"Martina","family":"Iulini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Beekmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron L. A. P.","family":"Hoogenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Fragki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Paini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7610-9796","authenticated-orcid":false,"given":"Aafke W. F.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"6","key":"4377_CR2","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00204-020-02715-4","volume":"94","author":"K Abraham","year":"2020","unstructured":"Abraham K, Mielke H, Fromme H, V\u00f6lkel W, Menzel J, Peiser M, Zepp F, Willich SN, Weikert C (2020) Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Arch Toxicol 94(6):2131\u20132147. https:\/\/doi.org\/10.1007\/s00204-020-02715-4","journal-title":"Arch Toxicol"},{"key":"4377_CR3","unstructured":"Allen JG. Opinion: These toxic chemicals are everywhere \u2014 even in your body. And they won\u2019t ever go away. The Washington Post. 2 January 2018. ISSN 0190\u20138286."},{"issue":"8","key":"4377_CR4","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00204-022-03303-4","volume":"96","author":"E Antoniou","year":"2022","unstructured":"Antoniou E, Colnot T, Zeegers M, Dekant W (2022) Immunomodulation and exposure to per- and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies. Arch Toxicol 96(8):2261\u20132285. https:\/\/doi.org\/10.1007\/s00204-022-03303-4","journal-title":"Arch Toxicol"},{"issue":"5234","key":"4377_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-\u03baB activity through induction of I\u03baB synthesis. Science 270(5234):286\u2013290. https:\/\/doi.org\/10.1126\/science.270.5234.286","journal-title":"Science"},{"issue":"2\u20133","key":"4377_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","volume":"120","author":"U Baschant","year":"2010","unstructured":"Baschant U, Tuckermann J (2010) The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120(2\u20133):69\u201375. https:\/\/doi.org\/10.1016\/j.jsbmb.2010.03.058","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"4377_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ki.2012.272","volume":"82","author":"B Becknell","year":"2012","unstructured":"Becknell B, Greenbaum LA, Smoyer WE (2012) A new tac for childhood nephroticsyndrome. Kidney Int 82(10):1049\u20131051. https:\/\/doi.org\/10.1038\/ki.2012.272","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"4377_CR9","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1016\/j.psyneuen.2009.05.021","volume":"34","author":"EB Binder","year":"2009","unstructured":"Binder EB (2009) The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34(Suppl 1):S186\u2013S195. https:\/\/doi.org\/10.1016\/j.psyneuen.2009.05.021","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"4377_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4049\/jimmunol.1901135","volume":"205","author":"DW Cain","year":"2020","unstructured":"Cain DW, Bortner CD, Diaz-Jimenez D, Petrillo MG, Gruver-Yates A, Cidlowski JA (2020) Murine glucocorticoid receptors orchestrate B cell migration selectively between bone marrow and blood. J Immunol 205(3):619\u2013629. https:\/\/doi.org\/10.4049\/jimmunol.1901135","journal-title":"J Immunol"},{"issue":"SUPPL. 1","key":"4377_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000314224","volume":"92","author":"F Castinetti","year":"2010","unstructured":"Castinetti F, Conte-Devolx B, Brue T (2010) Medical treatment of Cushing\u2019s syndrome: glucocorticoid receptor antagonists and mifepristone. Neuroendocrinology 92(SUPPL. 1):125\u2013130. https:\/\/doi.org\/10.1159\/000314224","journal-title":"Neuroendocrinology"},{"key":"4377_CR12","doi-asserted-by":"publisher","unstructured":"Christofides A, Konstantinidou E, Jani C, Vassiliki A, Israel B, Medical D (2022) The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. 1\u201334. https:\/\/doi.org\/10.1016\/j.metabol.2020.154338.","DOI":"10.1016\/j.metabol.2020.154338"},{"key":"4377_CR13","doi-asserted-by":"publisher","unstructured":"EFSA CONTAM PANEL, Schrenk D, Bignami M, Bodin L, Chipman JK, del Mazo J, Grasl-Kraupp B, Hogstrand C, Hoogenboom L, Leblanc JC, Nebbia CS, Nielsen E, Ntzani E, Petersen A, Sand S, Vleminckx C, Wallace H, Barreg\u00e5rd L, Ceccatelli S, Schwerdtle T (2020). Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA J, vol18(9). https:\/\/doi.org\/10.2903\/j.efsa.2020.6223","DOI":"10.2903\/j.efsa.2020.6223"},{"issue":"2","key":"4377_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.taap.2010.11.004","volume":"250","author":"E Corsini","year":"2011","unstructured":"Corsini E, Avogadro A, Galbiati V, Marinovich M, Galli CL, Germolec DR (2011) In vitro evaluation of the immunotoxic potential of per fl uorinated compounds ( PFCs ). Toxicol Appl Pharmacol 250(2):108\u2013116. https:\/\/doi.org\/10.1016\/j.taap.2010.11.004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"4377_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.taap.2011.11.004","volume":"258","author":"E Corsini","year":"2012","unstructured":"Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, Galli CL, Dell\u2019Agli M, Germolec DR (2012) In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol 258(2):248\u2013255. https:\/\/doi.org\/10.1016\/j.taap.2011.11.004","journal-title":"Toxicol Appl Pharmacol"},{"key":"4377_CR16","doi-asserted-by":"publisher","unstructured":"Corsini E, Galbiati V, Esser PR, Pinto A, Racchi M, Marinovich M, Martin SF, Galli CL, & Diacylglycerol, D. A. G. (2014). Role of PKC \u2011 \u03b2 in chemical allergen \u2011 induced CD86 expression and IL \u2011 8 release in THP \u2011 1 cells. 415\u2013424. https:\/\/doi.org\/10.1007\/s00204-013-1144-z","DOI":"10.1007\/s00204-013-1144-z"},{"key":"4377_CR17","doi-asserted-by":"publisher","unstructured":"Corsini E, Iulini M, Galbiati V, Maddalon A, Pappalardo F, Russo G, Hoogenboom RLAP, Janssen AWF, Louisse J, Fragki S, Paini A (2024) EFSA Project on the use of NAMs to explore the immunotoxicity of PFAS. https:\/\/doi.org\/10.2903\/sp.efsa.2024.EN-8926","DOI":"10.2903\/sp.efsa.2024.EN-8926"},{"issue":"6","key":"4377_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/s1074-7613(00)80398-2","volume":"7","author":"F D'Adamio","year":"1997","unstructured":"D\u2019Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorati G, Riccardi C (1997) A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR\/CD3-activated cell death. Immunity 7(6):803\u2013812. https:\/\/doi.org\/10.1016\/s1074-7613(00)80398-2","journal-title":"Immunity"},{"key":"4377_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.envint.2016.08.026","volume":"96","author":"L Dalsager","year":"2016","unstructured":"Dalsager L, Christensen N, Husby S, Kyhl H, Nielsen F, H\u00f8st A, Grandjean P, Jensen TK (2016) Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1\u20134years among 359 children in the Odense Child Cohort. Environ Int 96:58\u201364. https:\/\/doi.org\/10.1016\/j.envint.2016.08.026","journal-title":"Environ Int"},{"key":"4377_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.toxlet.2021.09.002","volume":"351","author":"S De Guise","year":"2021","unstructured":"De Guise S, Levin M (2021) Suppression of Th2 cytokines as a potential mechanism for reduced antibody response following PFOA exposure in female B6C3F1 mice. Toxicol Lett 351:155\u2013162. https:\/\/doi.org\/10.1016\/j.toxlet.2021.09.002","journal-title":"Toxicol Lett"},{"issue":"5","key":"4377_CR22","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1289\/ehp.10896","volume":"116","author":"JC Dewitt","year":"2008","unstructured":"Dewitt JC, Copeland CB, Strynar MJ, Luebke RW (2008) Perfluorooctanoic acid-induced immunomodulation in adult C57BL\/6J or C57BL\/6N female mice. Environ Health Perspect 116(5):644\u2013650. https:\/\/doi.org\/10.1289\/ehp.10896","journal-title":"Environ Health Perspect"},{"issue":"1","key":"4377_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/1547691X.2014.996682","volume":"13","author":"JC DeWitt","year":"2016","unstructured":"DeWitt JC, Williams WC, Creech NJ, Luebke RW (2016) Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: role of PPAR\u03b1 and T- and B-cell targeting. J Immunotoxicol 13(1):38\u201345. https:\/\/doi.org\/10.3109\/1547691X.2014.996682","journal-title":"J Immunotoxicol"},{"issue":"9","key":"4377_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00204-009-0424-0","volume":"83","author":"GH Dong","year":"2009","unstructured":"Dong GH, Zhang YH, Zheng L, Liu W, Jin YH, He QC (2009) Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL\/6 mice. Arch Toxicol 83(9):805\u2013815. https:\/\/doi.org\/10.1007\/s00204-009-0424-0","journal-title":"Arch Toxicol"},{"issue":"1","key":"4377_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12940-022-00958-5","volume":"22","author":"V Ehrlich","year":"2023","unstructured":"Ehrlich V, Bil W, Vandebriel R, Granum B, Luijten M, Lindeman B, Grandjean P, Kaiser AM, Hauzenberger I, Hartmann C, Gundacker C, Uhl M (2023) Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS). Environ Health 22(1):1\u201347. https:\/\/doi.org\/10.1186\/s12940-022-00958-5","journal-title":"Environ Health"},{"key":"4377_CR26","unstructured":"EPA (2022) Technical Fact Sheet: Drinking Water Health Advisories for Four PFAS (PFOA, PFOS, GenX chemicals, and PFBS); EPA 822-F-22\u2013002. https:\/\/www.epa.gov\/system\/files\/documents\/2022-06\/technical-factsheet-four-PFAS.pdf"},{"issue":"38","key":"4377_CR27","doi-asserted-by":"publisher","first-page":"26263","DOI":"10.1074\/jbc.M114.582882","volume":"289","author":"AG Erlejman","year":"2014","unstructured":"Erlejman AG, De Leo SA, Mazaira GI, Molinari AM, Camisay MF, Fontana V, Cox MB, Piwien-Pilipuk G, Galigniana MD (2014) NF-\u03baB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity. J Biol Chem 289(38):26263\u201326276. https:\/\/doi.org\/10.1074\/jbc.M114.582882","journal-title":"J Biol Chem"},{"issue":"2","key":"4377_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1021\/acs.est.3c07415","volume":"58","author":"FC Fischer","year":"2024","unstructured":"Fischer FC, Ludtke S, Thackray C, Pickard HM, Haque F, Dassuncao C, Endo S, Schaider L, Sunderland EM (2024) Binding of per- and polyfluoroalkyl substances (PFAS) to serum proteins: implications for toxicokinetics in humans. Environ Sci Technol 58(2):1055\u20131063. https:\/\/doi.org\/10.1021\/acs.est.3c07415","journal-title":"Environ Sci Technol"},{"issue":"1","key":"4377_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/1547691X.2018.1445145","volume":"15","author":"RP Frawley","year":"2018","unstructured":"Frawley RP, Smith M, Cesta MF, Hayes-Bouknight S, Blystone C, Kissling GE, Harris S, Germolec D (2018) Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B6C3F1\/N mice when administered by oral gavage for 28 days. J Immunotoxicol 15(1):41\u201352. https:\/\/doi.org\/10.1080\/1547691X.2018.1445145","journal-title":"J Immunotoxicol"},{"issue":"1","key":"4377_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1096\/fj.01-0245com","volume":"16","author":"J Galon","year":"2002","unstructured":"Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O\u2019Shea JJ, Chrousos GP, Bornstein SR (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16(1):61\u201371. https:\/\/doi.org\/10.1096\/fj.01-0245com","journal-title":"FASEB J"},{"key":"4377_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.727037","volume":"9","author":"IM Gans","year":"2021","unstructured":"Gans IM, Grendler J, Babich R, Jayasundara N, Coffman JA (2021) Glucocorticoid-responsive transcription factor Kr\u00fcppel-Like Factor 9 regulates fkbp5 and metabolism. Front Cell Dev Biol 9:727037. https:\/\/doi.org\/10.3389\/fcell.2021.727037","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"4377_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jama.2011.2034","volume":"307","author":"P Grandjean","year":"2012","unstructured":"Grandjean P, Andersen EW, Budtz-J\u00f8rgensen E, Nielsen F, M\u00f8lbak Ka\u00b0re, Weihe P, Heilmann C (2012) Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307(4):391\u2013397","journal-title":"JAMA"},{"issue":"1","key":"4377_CR33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/1547691X.2017.1360968","volume":"14","author":"P Grandjean","year":"2017","unstructured":"Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Timmermann A, Budtz-J\u00f8rgensen E (2017) Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years. J Immunotoxicol 14(1):188\u2013195. https:\/\/doi.org\/10.1080\/1547691X.2017.1360968","journal-title":"J Immunotoxicol"},{"issue":"4","key":"4377_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/1547691X.2012.755580","volume":"10","author":"B Granum","year":"2013","unstructured":"Granum B, Haug LS, Namork E, St\u00f8levik SB, Thomsen C, Aaberge IS, Van Loveren H, L\u00f8vik M, Nygaard UC (2013) Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 10(4):373\u2013379. https:\/\/doi.org\/10.3109\/1547691X.2012.755580","journal-title":"J Immunotoxicol"},{"issue":"1","key":"4377_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/pollutants4010009","volume":"4","author":"Z Habib","year":"2024","unstructured":"Habib Z, Song M, Ikram S, Zahra Z (2024) Overview of Per- and polyfluoroalkyl substances (PFAS), their applications, sources, and potential impacts on human health. Pollutants 4(1):136\u2013152. https:\/\/doi.org\/10.3390\/pollutants4010009","journal-title":"Pollutants"},{"issue":"4","key":"4377_CR36","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.4049\/jimmunol.161.4.1883","volume":"161","author":"P H\u00f6gger","year":"1998","unstructured":"H\u00f6gger P, Anne Droste JD, Buck F, Sorg C (1998) Identification of the integral membrane protein RM3\/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 161(4):1883\u20131890. https:\/\/doi.org\/10.4049\/jimmunol.161.4.1883","journal-title":"J Immunol"},{"issue":"5","key":"4377_CR37","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00204-025-03993-6","volume":"99","author":"M Iulini","year":"2025","unstructured":"Iulini M, Bettinsoli V, Maddalon A, Galbiati V, Janssen AWF, Beekmann K, Russo G, Pappalardo F, Fragki S, Paini A, Corsini E (2025) In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs. Arch Toxicol 99(5):2075\u20132086. https:\/\/doi.org\/10.1007\/s00204-025-03993-6","journal-title":"Arch Toxicol"},{"issue":"2","key":"4377_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00204-022-03405-z","volume":"97","author":"AWF Janssen","year":"2023","unstructured":"Janssen AWF, Louisse J, Rijkers D, Pinckaers NET, Hoekstra SA, Hoogenboom RLAP, Peijnenburg AACM, Beekmann K (2023) Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. Arch Toxicol 97(2):457\u2013468. https:\/\/doi.org\/10.1007\/s00204-022-03405-z","journal-title":"Arch Toxicol"},{"key":"4377_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/ftox.2024.1347965","volume":"6","author":"AWF Janssen","year":"2024","unstructured":"Janssen AWF, Jansen Holleboom W, Rijkers D, Louisse J, Hoekstra SA, Schild S, Vrolijk MF, Hoogenboom RLAP, Beekmann K (2024a) Determination of in vitro immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cells. Front Toxicol 6:1\u201315. https:\/\/doi.org\/10.3389\/ftox.2024.1347965","journal-title":"Front Toxicol"},{"issue":"1","key":"4377_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74802-w","volume":"14","author":"AWF Janssen","year":"2024","unstructured":"Janssen AWF, van der Lugt B, Duivenvoorde LPM, Vos AP, Bastiaan-Net S, Tomassen MMM, Verbokkem JAC, Blok-Heimerikx E, Hooiveld GJEJ, van Baarlen P, Ferrier L, van der Zande M (2024b) Comparison of iPSC-derived human intestinal epithelial cells with Caco-2 cells and human in vivo data after exposure to Lactiplantibacillus plantarum WCFS1. Sci Rep 14(1):26464. https:\/\/doi.org\/10.1038\/s41598-024-74802-w","journal-title":"Sci Rep"},{"issue":"2","key":"4377_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/1547691X.2015.1067259","volume":"13","author":"K Kielsen","year":"2016","unstructured":"Kielsen K, Shamim Z, Ryder LP, Nielsen F, Grandjean P, Budtz-J\u00f8rgensen E, Heilmann C (2016) Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J Immunotoxicol 13(2):270\u2013273. https:\/\/doi.org\/10.3109\/1547691X.2015.1067259","journal-title":"J Immunotoxicol"},{"issue":"8","key":"4377_CR42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL (2019) Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 37(8):907\u2013915. https:\/\/doi.org\/10.1038\/s41587-019-0201-4","journal-title":"Nat Biotechnol"},{"key":"4377_CR44","doi-asserted-by":"publisher","unstructured":"Komatsu H, Sugimoto J, Goto K, Kushima K, Tsutsui N, Hisada S, Ito S, Kosaka T, Ohishi T,Otsubo Y, Takahashi Y 2021 Adverse Outcome Pathway on inhibition of calcineurinactivity leading to impaired T-cell dependent antibody response. OECD Series on AdverseOutcome Pathways, No. 18, OECD Publishing, Paris, https:\/\/doi.org\/10.1787\/3c988dde-en.","DOI":"10.1787\/3c988dde-en"},{"issue":"2","key":"4377_CR45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/en.2013-2085","volume":"155","author":"WJ Kovacs","year":"2014","unstructured":"Kovacs WJ (2014) To B or not to B? Glucocorticoid impact on B lymphocyte fate and function. Endocrinol 155(2):339\u2013341. https:\/\/doi.org\/10.1210\/en.2013-2085","journal-title":"Endocrinol"},{"issue":"18","key":"4377_CR46","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1128\/MCB.00150-13","volume":"33","author":"WM Lambert","year":"2013","unstructured":"Lambert WM, Xu CF, Neubert TA, Chao MV, Garabedian MJ, Jeanneteau FD (2013) Brain-derived neurotrophic factor signaling rewrites the glucocorticoid transcriptome via glucocorticoid receptor phosphorylation. Mol Cell Biol 33(18):3700\u20133714. https:\/\/doi.org\/10.1128\/MCB.00150-13","journal-title":"Mol Cell Biol"},{"key":"4377_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153321","volume":"480","author":"M Masi","year":"2022","unstructured":"Masi M, Maddalon A, Iulini M, Linciano P, Galbiati V, Marinovich M, Racchi M, Corsini E, Buoso E (2022) Effects of endocrine disrupting chemicals on the expression of RACK1 and LPS-induced THP-1 cell activation. Toxicology 480:153321. https:\/\/doi.org\/10.1016\/j.tox.2022.153321","journal-title":"Toxicology"},{"issue":"1","key":"4377_CR49","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/toxsci\/kfaa138","volume":"178","author":"CA McDonough","year":"2020","unstructured":"McDonough CA, Ward C, Hu Q, Vance S, Higgins CP, DeWitt JC (2020) Immunotoxicity of an electrochemically fluorinated aqueous film-forming foam. Toxicol Sci 178(1):104\u2013114. https:\/\/doi.org\/10.1093\/toxsci\/kfaa138","journal-title":"Toxicol Sci"},{"issue":"18","key":"4377_CR50","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1101\/gad.827900","volume":"14","author":"RM Nissen","year":"2000","unstructured":"Nissen RM, Yamamoto KR (2000) The glucocorticoid receptor inhibits NF\u03baB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14(18):2314\u20132329. https:\/\/doi.org\/10.1101\/gad.827900","journal-title":"Genes Dev"},{"key":"4377_CR51","doi-asserted-by":"publisher","DOI":"10.1067\/MAI.2000.110923","author":"K Ohta","year":"2000","unstructured":"Ohta K (2000) Glucocorticoids preferentially upregulate functional CXCR4 expression in eosinophils. J Allergy Clin Immunol. https:\/\/doi.org\/10.1067\/MAI.2000.110923","journal-title":"J Allergy Clin Immunol"},{"key":"4377_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2025.120976","volume":"270","author":"AM Padula","year":"2025","unstructured":"Padula AM, Salihovic S, Zazara DE, Diemert A, Arck PC (2025) Prenatal per- and polyfluoroalkyl substances in relation to antibody titers and infections in childhood. Environ Res 270:120976. https:\/\/doi.org\/10.1016\/j.envres.2025.120976","journal-title":"Environ Res"},{"issue":"1","key":"4377_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/toxsci\/kfn059","volume":"104","author":"MM Peden-Adams","year":"2008","unstructured":"Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE (2008) Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 104(1):144\u2013154. https:\/\/doi.org\/10.1093\/toxsci\/kfn059","journal-title":"Toxicol Sci"},{"issue":"6","key":"4377_CR54","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ccr.2013.10.022","volume":"24","author":"E Piovan","year":"2013","unstructured":"Piovan E, Yu J, Tosello V, Herranz D, Ambesi-Impiombato A, Da Silva AC, Sanchez-Martin M, Perez-Garcia A, Rigo I, Castillo M, Indraccolo S, Cross JR, de Stanchina E, Paietta E, Racevskis J, Rowe JM, Tallman MS, Basso G, Meijerink JP, Cordon-Cardo C, Da Silva A, Cross J, Rowe J, Tallman M, Meijerink J, Califano A, Ferrando A, Ferrando AA (2013) Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. Cancer Cell 24(6):766\u2013776. https:\/\/doi.org\/10.1016\/j.ccr.2013.10.022","journal-title":"Cancer Cell"},{"key":"4377_CR55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.tox.2009.10.035","volume":"267","author":"MR Qazi","year":"2010","unstructured":"Qazi MR, Nelson BD, Depierre JW, Abedi-Valugerdi M (2010) 28-Day dietary exposure of mice to a low total dose (7 mg\/kg) of perfuorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity? Toxicology 267:132\u2013139. https:\/\/doi.org\/10.1016\/j.tox.2009.10.035","journal-title":"Toxicology"},{"issue":"7","key":"4377_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"4377_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfw251","author":"BR Rushing","year":"2017","unstructured":"Rushing BR, Hu Q, Franklin JN, McMahen R, Dagnino S, Higgins CP, Strynar MJ, DeWitt JC (2017) Evaluation of the immunomodulatory effects of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in C57BL\/6 mice. Toxicol Sci off J Soc Toxicol. https:\/\/doi.org\/10.1093\/toxsci\/kfw251","journal-title":"Toxicol Sci off J Soc Toxicol"},{"issue":"7","key":"4377_CR59","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/nar\/29.7.1399","volume":"29","author":"MJ Sadofsky","year":"2001","unstructured":"Sadofsky MJ (2001) The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res 29(7):1399\u20131409. https:\/\/doi.org\/10.1093\/nar\/29.7.1399","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4377_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/1547691X.2021.1922957","volume":"18","author":"YH Shih","year":"2021","unstructured":"Shih YH, Blomberg AJ, Bind MA, Holm D, Nielsen F, Heilmann C, Weihe P, Grandjean P (2021) Serum vaccine antibody concentrations in adults exposed to per- and polyfluoroalkyl substances: a birth cohort in the Faroe Islands. J Immunotoxicol 18(1):85\u201392. https:\/\/doi.org\/10.1080\/1547691X.2021.1922957","journal-title":"J Immunotoxicol"},{"issue":"43","key":"4377_CR63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4377_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/eji.201948241","volume":"50","author":"P Tuijnenburg","year":"2020","unstructured":"Tuijnenburg P, Aan de Kerk DJ, Jansen MH, Morris B, Lieftink C, Beijersbergen RL, van Leeuwen EMM, Kuijpers TW (2020) High\u2010throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells. Eur J Immunol 50(1):73\u201385. https:\/\/doi.org\/10.1002\/eji.201948241","journal-title":"Eur J Immunol"},{"key":"4377_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113218","volume":"152","author":"L Van Moortel","year":"2022","unstructured":"Van Moortel L, Thommis J, Maertens B, Staes A, Clarisse D, De Sutter D, Libert C, Meijer OC, Eyckerman S, Gevaert K, De Bosscher K (2022) Novel assays monitoring direct glucocorticoid receptor protein activity exhibit high predictive power for ligand activity on endogenous gene targets. Biomed Pharmacother 152:113218. https:\/\/doi.org\/10.1016\/j.biopha.2022.113218","journal-title":"Biomed Pharmacother"},{"key":"4377_CR67","doi-asserted-by":"publisher","unstructured":"Wei Q, Liang G, Yuancheng Li R, Hong A, Wang H, Feng S, Wang T, Wang Y (2023) Glucocorticoid receptor activation induces NK cells to produce AREG and restricts their anti-tumor activity in skin cancer. bioRxiv 2023.09.13.557530; https:\/\/doi.org\/10.1101\/2023.09.13.557530","DOI":"10.1101\/2023.09.13.557530"},{"issue":"5","key":"4377_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/toxics9050100","volume":"9","author":"T Woodlief","year":"2021","unstructured":"Woodlief T, Vance S, Hu Q, DeWitt J (2021) Immunotoxicity of Per- and Polyfluoroalkyl Substances: insights into short-chain PFAS exposure. Toxics 9(5):100. https:\/\/doi.org\/10.3390\/toxics9050100","journal-title":"Toxics"},{"issue":"1","key":"4377_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/npp.2015.235","volume":"41","author":"AS Zannas","year":"2016","unstructured":"Zannas AS, Wiechmann T, Gassen NC, Binder EB (2016) Gene-stress-epigeneticregulation of FKBP5: clinical and translational implications. Neuropsychopharmacology 41(1):261\u2013274. https:\/\/doi.org\/10.1038\/npp.2015.235","journal-title":"Neuropsychopharmacology"},{"key":"4377_CR70","doi-asserted-by":"publisher","unstructured":"Zannas AS, Jia M, Hafner K, Baumert J, Wiechmann T, Pape JC, Arloth J, K\u00f6del M, Martinelli S, Roitman M, R\u00f6h S, Haehle A, Emeny RT, Iurato S, Carrillo-Roa T, Lahti J, R\u00e4ikk\u00f6nen K,Eriksson JG, Drake AJ,Waldenberger M, Wahl S, Kunze S, Lucae S, Bradley B, Gieger C,Hausch F, Smith AK, Ressler KJ, M\u00fcller-Myhsok B, Ladwig K-H, Rein T, Gassen NC, Binder EB (2019) Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk. Proc Natl Acad Sci United States of America, 166(23), 11370\u201311379.https:\/\/doi.org\/10.1073\/pnas.1816847116","DOI":"10.1073\/pnas.1816847116"},{"issue":"7","key":"4377_CR71","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00204-008-0361-3","volume":"83","author":"L Zheng","year":"2009","unstructured":"Zheng L, Dong GH, Jin YH, He QC (2009) Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL\/6 mice. Arch Toxicol 83(7):679\u2013689. https:\/\/doi.org\/10.1007\/s00204-008-0361-3","journal-title":"Arch Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04377-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04377-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04377-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:19:42Z","timestamp":1782512382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04377-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4377"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04377-0","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}